Deal snapshot: UK Biotech MiroBio Agrees to USD 405m Gilead Sciences Buyout.

MANews-(C)2009-2022

UK-based biotechnology company MiroBio Ltd has entered into a definitive agreement with US-based Gilead Sciences (NASDAQ: GILD), Inc. to be acquired for approximately USD 405m in cash, subject to customary adjustments, the firm said.

MiroBio is focused on restoring immune balance with agonists targeting immune inhibitory receptors. MiroBio was spun out of the...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT